Geno

Hyosung TNC Invests $1 Billion in Future "Bio" Business

Retrieved on: 
Monday, April 1, 2024

Chairman Hyun-Joon Cho states, "The bio business will become a core pillar of Hyosung for the next 100 years.

Key Points: 
  • Chairman Hyun-Joon Cho states, "The bio business will become a core pillar of Hyosung for the next 100 years.
  • SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Hyun-Joon Cho, chairman of Hyosung announces major investment in the bio business, embarking on future new business ventures.
  • Hyosung TNC plans to proactively respond to the global materials market's reorganization around sustainable products by investing $1 billion to establish multiple Bio-BDO production plants capable of producing 200,000 tons annually.
  • From Raw Material to Fiber, Hyosung TNC Establishes the World's First Fully-Integrated Production System for Bio-Spandex
    With this investment, Hyosung TNC has secured the largest bio-spandex factory in Vietnam.

Hyosung TNC Invests $1 Billion in Future "Bio" Business

Retrieved on: 
Monday, April 1, 2024

Chairman Hyun-Joon Cho states, "The bio business will become a core pillar of Hyosung for the next 100 years.

Key Points: 
  • Chairman Hyun-Joon Cho states, "The bio business will become a core pillar of Hyosung for the next 100 years.
  • SEOUL, South Korea, March 31, 2024 /PRNewswire/ -- Hyun-Joon Cho, chairman of Hyosung announces major investment in the bio business, embarking on future new business ventures.
  • Hyosung TNC plans to proactively respond to the global materials market's reorganization around sustainable products by investing $1 billion to establish multiple Bio-BDO production plants capable of producing 200,000 tons annually.
  • From Raw Material to Fiber, Hyosung TNC Establishes the World's First Fully-Integrated Production System for Bio-Spandex
    With this investment, Hyosung TNC has secured the largest bio-spandex factory in Vietnam.

Future Origins Launches from Joint Venture to Develop Sustainable Ingredients in Personal Care and Cleaning Products, Announces Completion of Pilot Scale Activities

Retrieved on: 
Wednesday, January 31, 2024

SAN DIEGO, Jan. 31, 2024 /PRNewswire/ -- Future Origins, a U.S. based joint venture that is commercializing sustainable alternatives to critical ingredients in the formulations of everyday cosmetics, personal care and cleaning products, formally launched today at the American Cleaning Institute's Innovation Showcase. Future Origins was founded by industrial biotechnology leader Geno, Unilever, Kao, and L'Oréal to commercialize and manufacture high-volume sustainable ingredients for widely used surfactants such as laundry detergent and face wash.

Key Points: 
  • Future Origins is shipping these products to commercial partners for use in a variety of applications.
  • "We are at a moment in time where the innovation in biotechnology is meeting the demand for sustainable alternatives.
  • Future Origins will use Geno's proven fermentation-based technology and proprietary engineered microorganisms to produce more sustainable surfactants.
  • While product development activities continue to advance, Future Origins plans to have their first commercial-scale manufacturing plant under construction by 2025.

IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing

Retrieved on: 
Tuesday, November 7, 2023

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.

Key Points: 
  • Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.
  • IDTechEx has analyzed over thirty-five different molecules and compounds in their market research report " White Biotechnology 2024-2034 "; here are some of the most interesting molecules whose biomanufacturing development is worth monitoring.
  • Polyamide precursors: one emerging category of biomanufactured molecules are key precursors for polyamides like PA 6 and PA 66.
  • These profiled molecules are just the tip of the iceberg when it comes to the new types of molecules being produced through white biotechnology.

IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing

Retrieved on: 
Tuesday, November 7, 2023

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.

Key Points: 
  • Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.
  • IDTechEx has analyzed over thirty-five different molecules and compounds in their market research report " White Biotechnology 2024-2034 "; here are some of the most interesting molecules whose biomanufacturing development is worth monitoring.
  • Polyamide precursors: one emerging category of biomanufactured molecules are key precursors for polyamides like PA 6 and PA 66.
  • These profiled molecules are just the tip of the iceberg when it comes to the new types of molecules being produced through white biotechnology.

Agiloft Announces Partnership with Mitratech, Integrating Best-in-Class CLM and ELM Systems, at CLOC Global Institute 2023

Retrieved on: 
Tuesday, May 16, 2023

LAS VEGAS, May 16, 2023 /PRNewswire/ -- CLOC – At the Corporate Legal Operations Consortium (CLOC)'s flagship event in Las Vegas, Agiloft, the global standard in no-code contract lifecycle management (CLM) software, announced a new partnership with Mitratech, the leading global provider of legal, compliance, and HR software. The partnership aims to simplify the increasingly complex tech stack that legal departments face, first through delivery of a seamless connection between Mitratech's TeamConnect and Agiloft's CLM. Integration of the two applications will provide legal operations and in-house legal users with greater efficiency, visibility, and control by automating workflows and improving data exchange across contracts and legal matters.

Key Points: 
  • The partnership aims to simplify the increasingly complex tech stack that legal departments face, first through delivery of a seamless connection between Mitratech's TeamConnect and Agiloft's CLM.
  • Integration of the two applications will provide legal operations and in-house legal users with greater efficiency, visibility, and control by automating workflows and improving data exchange across contracts and legal matters.
  • "We could not be more excited to partner with Mitratech and continue our mission of building the most integrated enterprise CLM on the market," said Eric Laughlin, Agiloft CEO.
  • "The most powerful CLM systems connect with cross-functional business systems that drive strategic processes and let data flow seamlessly across an organization.

L'Oréal Becomes Third Global Company to Invest in Geno-led Venture for Sustainably Sourced Ingredients

Retrieved on: 
Monday, March 20, 2023

The venture is poised to offer highly effective and sustainable ingredients for the combined $571B beauty and personal care markets.

Key Points: 
  • The venture is poised to offer highly effective and sustainable ingredients for the combined $571B beauty and personal care markets.
  • Geno's biotechnology platform will be used to develop sustainable alternatives to critical ingredients in everyday cosmetics, personal care, and cleaning products.
  • The venture's founding members, Geno, Unilever, Kao Corporation and now L'Oréal, have combined revenues exceeding $100B/yr, and marquee globally branded product portfolios that reach billions of people.
  • Geno will deploy its proven biotechnology platform, using proprietary engineered microorganisms to ferment plant sugars that produce ingredients to make sustainable surfactants.

Agiloft Launches "GenO: The Rise of Legal Operations," a New Series from the Contract Insights Podinar Featuring Legal Operations Leaders from Around the World

Retrieved on: 
Tuesday, March 14, 2023

REDWOOD CITY, Calif., March 14, 2023 /PRNewswire/ -- Agiloft, the global standard in agile contract lifecycle management (CLM), today launched the new "GenO: The Rise of Legal Operations" interview series on its must-watch Contract Insights podinar. GenO will feature in-depth conversations with legal operations leaders, General Counsel, and business leaders, who have supported the establishment of this role and benefitted from the unique talents of legal operations professionals, chronicling the central role they are playing in the revolution of law departments and the enterprise.

Key Points: 
  • REDWOOD CITY, Calif., March 14, 2023 /PRNewswire/ -- Agiloft , the global standard in agile contract lifecycle management (CLM), today launched the new "GenO: The Rise of Legal Operations" interview series on its must-watch Contract Insights podinar.
  • "Legal operations has evolved from a function into a profession in the past decade," said Eric Laughlin, CEO of Agiloft.
  • Furthermore, legal operations professionals initiate and lead programs that impact the entire corporation, not just the Legal Department.
  • Tune in to hear Prashant's interview with Mike Haven and Steve Harmon, as well as other episodes of the GenO interview series from Contract Insights here .

Geno CEO Named Top 40 Power Player by ICIS Award for Second Straight Year

Retrieved on: 
Thursday, January 26, 2023

SAN DIEGO and LONDON, Jan. 26, 2023 /PRNewswire/ -- Today, Christophe Schilling, co-founder and CEO at Geno, a sustainable materials leader, was included on the 2023 ICIS Top 40 Power Players, a global ranking of the leading CEOs and senior executives driving positive impact in their companies and the chemical industry. This year's recognition is the second consecutive year Schilling has won this award, and the third time he's earned the honor in the past five rankings. Geno is the only biotech company to make this year's list as it continues to scale sustainable materials to improve the sustainability profile of some of the most popular chemicals on the market—including BDO and nylon-6.

Key Points: 
  • This year's recognition is the second consecutive year Schilling has won this award, and the third time he's earned the honor in the past five rankings.
  • This award win caps a year of significant momentum for Geno.
  • It's an honor to be recognized alongside industry leaders I admire who are working in parallel to transform the chemical industry."
  • Geno recently won the ICIS Innovation Award for the third straight year, winning the award for Best Product Innovation from a SME for advances in developing plant-based nylon-6 to slash greenhouse gas emissions from textiles, films and plastics.

Geno Enters Functional Foods and Beverages Market With New, Breakthrough Ingredient

Retrieved on: 
Wednesday, November 2, 2022

SAN DIEGO, Nov. 2, 2022 /PRNewswire/ -- Today, sustainability leader Geno announced its entry into the functional foods and beverages market with the launch of its new functional ingredient, Avela™ natural (R)-1,3-Butanediol. The novel, sugar-free ingredient, debuting at SupplySide West 2022 in Las Vegas, offers a fast, easy and accessible way to raise beta-hydroxybutyrate (BHB) ketone levels, the primary energy source made in the body during ketosis.

Key Points: 
  • As pure (R)-1,3-Butanediol, the ingredient is metabolized to form (D)-BHB, the same ketone that's naturally produced during ketosis.
  • After ingestion, Avela rapidly elevates BHB levels, providing a clean, sugar-free ketogenic energy source for use by muscles and the brain.
  • "And Geno is helping companies answer rising consumer demand for keto products across the globe safely and sustainably."
  • Geno's technology, built over the last 20 years, now drives materials and ingredients in applications ranging from cosmetics, carpets, and functional foods and beverages to home cleaners, apparel and more.